Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

340
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
340
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

356
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
356
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

770
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
770
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

6
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
6
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Anthelminthic Agents01:15

Anthelminthic Agents

96
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
96

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Left Gluteal and Perianal Eumycetoma Lesion Extending Into the Left Greater Sciatic Foramen, Pelvic Cavity to the External Anal Sphincter.

Clinical case reports·2026
Same author

Paresthesia and Facial Bone Destruction due to Chronic Granulomatous Invasive Aspergillosis in the Left Maxillary Sinus.

Clinical case reports·2026
Same author

Advances in the treatment of mycetoma: the emerging role of nanomedicine.

Nanomedicine (London, England)·2026
Same author

Molecular docking approaches in mycetoma: Toward improved patient management.

PLoS neglected tropical diseases·2026
Same author

Author Correction: The contribution of mycetoma grains to suboptimal disease management.

Nature communications·2026
Same author

The contribution of mycetoma grains to suboptimal disease management.

Nature communications·2025

Related Experiment Video

Updated: Apr 21, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

11.3K

Mycetoma medical therapy.

Oliverio Welsh1, Hail Mater Al-Abdely2, Mario Cesar Salinas-Carmona3

  • 1Department of Dermatology, Dr. Jose E. Gonzalez University Hospital, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.

Plos Neglected Tropical Diseases
|October 21, 2014
PubMed
Summary

Mycetoma treatment requires accurate diagnosis of fungal (eumycetoma) or bacterial (actinomycetoma) causes. This review assesses antimicrobial and antifungal drug effectiveness for these distinct mycetoma types.

More Related Videos

Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
09:37

Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings

Published on: December 4, 2021

9.9K
Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
07:14

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

1.9K

Related Experiment Videos

Last Updated: Apr 21, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

11.3K
Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings
09:37

Application of Lucilia sericata Larvae in Debridement of Pressure Wounds in Outpatient Settings

Published on: December 4, 2021

9.9K
Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
07:14

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

1.9K

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Antimicrobial Therapy

Background:

  • Mycetoma diagnosis is challenging due to overlapping clinical features between fungal (eumycetoma) and bacterial (actinomycetoma) infections.
  • Misdiagnosis leads to ineffective treatment and poor patient outcomes.
  • Accurate etiological identification is crucial for appropriate medical management.

Purpose of the Study:

  • To review the efficacy of current antimicrobial agents against actinomycetoma.
  • To evaluate the status of antifungal drugs used in treating eumycetoma.
  • To provide insights into optimizing mycetoma treatment strategies based on etiology.

Main Methods:

  • Literature review of studies on mycetoma treatment.
  • Analysis of clinical data on therapeutic responses to antimicrobial and antifungal drugs.
  • Comparative evaluation of treatment outcomes for actinomycetoma and eumycetoma.

Main Results:

  • Antimicrobial agents show variable efficacy in actinomycetoma, with specific drug classes demonstrating better outcomes.
  • Current antifungal treatments for eumycetoma are reviewed, highlighting their effectiveness and limitations.
  • The review identifies gaps in treatment guidelines and areas for future research.

Conclusions:

  • Distinguishing between actinomycetoma and eumycetoma is paramount for successful treatment.
  • Optimized therapeutic regimens require etiological confirmation.
  • Further research is needed to develop more effective and targeted treatments for both types of mycetoma.